PHS
CELC icon

PFM Health Sciences’s Celcuity CELC Stock Holding History

PFM Health Sciences’s Portfolio CELC Stock Details CELC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.46M Buy
+52,155
New +$6.02M 0.47% 67
2025
Q2 		– Sell
-53,349
Closed -$539K – 63
2025
Q1 		$539K Sell
53,349
-105,397
-66% -$1.19M 0.04% 63
2024
Q4 		$2.08M Sell
158,746
-551,509
-78% -$7.78M 0.13% 73
2024
Q3 		$10.6M Sell
710,255
-126,747
-15% -$2.09M 0.6% 38
2024
Q2 		$13.7M Buy
837,002
+340,000
+68% +$5.69M 0.68% 42
2024
Q1 		$10.7M Buy
497,002
+340,005
+217% +$5.43M 0.5% 54
2023
Q4 		$2.29M Sell
156,997
-53,554
-25% -$647K 0.14% 61
2023
Q3 		$1.92M Sell
210,551
-47,162
-18% -$464K 0.09% 68
2023
Q2 		$2.83M Sell
257,713
-53,252
-17% -$553K 0.11% 75
2023
Q1 		$3.19M Sell
310,965
-401,146
-56% -$4.4M 0.14% 67
2022
Q4 		$9.98M Buy
712,111
+571,685
+407% +$5.85M 0.36% 68
2022
Q3 		$1.41M Buy
+140,426
New +$1.33M 0.05% 83

Other funds holding CELC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFM Health Sciences's CELC Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Celcuity (CELC) in Q2 2026: 52,155 shares worth $5.46M. The stake represents 0.47% of the portfolio and ranks #67 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in CELC as recently as Q1 2025.

PFM Health Sciences first reported a position in CELC in Q3 2022 and has held it in 12 quarters since. The position peaked at $13.7M in Q2 2024. 274 funds tracked by Wall St. Rank hold CELC as of Q2 2026.

  • PFM Health Sciences held 52,155 shares of Celcuity worth $5.46M as of Q2 2026.
  • Celcuity was a new PFM Health Sciences position in Q2 2026.
  • Celcuity made up 0.47% of PFM Health Sciences's portfolio in Q2 2026, its #67 holding.
  • PFM Health Sciences first reported a position in Celcuity in Q3 2022 and has held it in 12 quarters since.
  • PFM Health Sciences's Celcuity position peaked at $13.7M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Celcuity as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.